Who Paid My Doc
Evusheld
Drug Vaccines & Immune Therapies
NDC 0310-7442-02
General payments
$249,720
Research payments
$134,630,404
Through program year 2025, $249,720 in general payments and $134,630,404 in research payments were reported against Evusheld (Vaccines & Immune Therapies).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,316 | 92 |
| 2025 | Research | $144,964 | 8 |
| 2024 | General | $7,377 | 18 |
| 2024 | Research | $8,618,312 | 171 |
| 2023 | General | $104,440 | 1,763 |
| 2023 | Research | $46,528,625 | 535 |
| 2022 | General | $134,587 | 2,716 |
| 2022 | Research | $79,338,503 | 574 |
Breakdown
The top 5 of 68 recipients; each share is of general payments naming this product in 2025.
The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
4,589 general · 1,288 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.